Organizational experience of the Civil Defense Scientific Research Center in the diagnosis of COVID-19

Authors

Keywords:

COVID-19, SARS-CoV-2, molecular biology, health, protection, laboratories.

Abstract

Facing the COVID-19 epidemic in Cuba has required the development of new capacities for its diagnosis in the molecular biology laboratories of different scientific and health institutions. The objective of this work is to show the experience of the Cuban Civil Defense Scientific Research Center in organizing the diagnosis of COVID-19. Guiding documents for the Center's work, its biosafety program, and those reported by the World Health Organization for dealing with the pandemic were reviewed. The experience of the structure adopted by the entity to ensure an uninterrupted diagnosis, the functions of the Steering Group and the sequence of activities carried out is exposed; highlighting the training of personnel in the management of biological risks and the prevention measures adopted. The proper use of collective and individual protection means, the safe handling of biological samples and cooperation with other entities, have allowed the fulfillment of the entrusted task, without the occurrence of accidents that compromise the health of the personnel working in the diagnosis, nor effects on the community and the environment.

Downloads

Download data is not yet available.

References

1. Redacción Minsap. Cuba fortalece el sistema de vigilancia para contener la introducción del nuevo coronavirus. Ministerio de Salud Pública, Noticias. 2020 [acceso: 28/01/2020]. Disponible en: https://salud.msp.gob.cu/cuba-fortalece-el-sistema-de-vigilancia-para-contener-la-introduccion-y-diseminacion-del-nuevo-coronavirus/

2. Prensa Latina. Llama Defensa Civil en Cuba a enfrentar con disciplina la Covid-19. Noticias. 2020 [acceso: 13/05/2020]. Disponible en: https://www.prensa-latina.cu/index.php?o=rn&id=365840&SEO=llama-defensa-civil-en-cuba-a-enfrentar-con-disciplina-la-covid-19

3. Prensa Latina. Cuba expondrá en foro virtual su experiencia sobre trabajo y Covid-19. Noticias. 2020 [acceso: 07/07/2020]. Disponible en: https://www.prensa-latina.cu/index.php?o=rn&id=379856&SEO=cuba-expondra-en-foro-virtual-su-experiencia-sobre-trabajo-y-covid-19

4. Presidencia y Gobierno de la República. Gobierno cubano actualiza el Plan para la prevención y control del COVID-19. Noticias. 2020 [acceso: 05/03/2020]. Disponible en: https://www.presidencia.gob.cu/es/noticias/gobierno-cubano-actualiza-el-plan-para-la-prevencion-y-control-del-covid-19-1/

5. Martínez-Díaz E, Pérez-Rodríguez R, Herrera-Martínez L, Lage-Dávila A, Castellanos-Serra L. La industria biofarmacéutica cubana en el combate contra la pandemia de COVID-19. Anales de la Academia de Ciencias de Cuba. 2020 [acceso: 20/8/2020]; 10(2):[aprox. 30 p.]. Disponible en: https://www.revistaccuba.cu/index.php/revacc/article/view/906/894

6. Cubaenresumen. Cuba: Nasalferón para evitar la replicación del SARS-CoV-2. Noticias. 2020 [acceso: 04/10/2020]. Disponible en: https://www.cubaenresumen.org/2020/10/cuba-nasalferon-para-evitar-la-replicacion-del-sars-cov-2/

7. Díaz-Canel Bermúdez M, Núñez Jover J. Government Management and Cuban Science in the confrontation with COVID-19. Anales de la Academia de Ciencias de Cuba. 2020 [acceso: 4/10/2020]; 10(2):[aprox. 10 p.]. Disponible en: https://www.revistaccuba.cu/index.php/revacc/article/view/881/893

Downloads

Published

2021-05-04

How to Cite

1.
Rodríguez Acosta M, Dubed Echevarría M, Pérez Guevara MT, Cruz Sui O, González Sosa NL, Hernández Sánchez T, et al. Organizational experience of the Civil Defense Scientific Research Center in the diagnosis of COVID-19. Rev Cubana Med Milit [Internet]. 2021 May 4 [cited 2024 Dec. 28];50(2):e02101326. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/1326

Issue

Vol. 50 No. 2 (2021): April - June

Section

Opinion Article

License

Authors who have publications with this Journal accept the following terms:

  • The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
  • The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
  • Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.

Most read articles by the same author(s)